The broad objective of the Opportunities Fund Management Core (OFMC) will be to facilitate early stage support for innovative or translational projects, particularly those which have the potential to lead to practical products in the fields of radiation biodosimetry and prediction and prevention of acute and delayed injuries. The OFMC will support 1) Pilot projects (basic and translational research) and 2) proposals that lead to Investigational New Drug (IND)-enabling studies and Medical Countermeasure (MCM) development. The OFMC will generate an SOP (Standard Operating Procedure) for the operation of the Core which, after Steering Committee approval, will be the template for its operation. Central to the process is getting the best possible set of applications to the OFMC, and the OFMC will use a unique two-phase mentor-based review program; The first phase is a mandatory pre-proposal Letter of Intent from potential applicants. This enables the OFMC to pair applicants with appropriate CMCRC scientists to create mentoring/advising opportunities that lead to stronger full proposals that are in tune with CMCRC issues and goals. The second phase, due six weeks later, is the submission of the full proposal. The OFMC will coordinate the process of soliciting Letters of Intent and subsequent Proposals, as well as coordinating the review of the proposals, and finally providing a set of review scores to the CMCRC Steering Committee. Innovative and translational research, as well as New or Early Stage Investigators, will be strongly emphasized in the review process. The OFMC will also be responsible for coordinating all necessary documentation of financial, IRB, and IACUC requirements with subrecipient institutions, as well as financial oversight and reporting. The OFMC will also coordinate annual progress reports, and based on these, will make funding renewal recommendations to the Steering Committee. Importantly, the OFMC will facilitate presentation opportunities for the pilot project recipients. All pilot awardees will be requested to prepare a poster for the annual CMCRC meeting. With the Steering Committee's approval, and based on these posters, the OFMC, in collaboration with the CCC, will propose and organize a poster mini-presentation session for pilot awardees at the CMCRC Annual Meeting.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program--Cooperative Agreements (U19)
Project #
2U19AI067773-11
Application #
8942467
Study Section
Special Emphasis Panel (ZAI1-PA-I (M2))
Project Start
2015-08-01
Project End
2020-07-31
Budget Start
2015-08-01
Budget End
2016-07-31
Support Year
11
Fiscal Year
2015
Total Cost
$3,482,990
Indirect Cost
$694,621
Name
Columbia University (N.Y.)
Department
Type
DUNS #
621889815
City
New York
State
NY
Country
United States
Zip Code
10032
Laiakis, Evagelia C; Mak, Tytus D; Strawn, Steven J et al. (2018) Global metabolomic responses in urine from atm deficient mice in response to LD50/30 gamma irradiation doses. Environ Mol Mutagen 59:576-585
Eppensteiner, John; Davis, Robert Patrick; Barbas, Andrew S et al. (2018) Immunothrombotic Activity of Damage-Associated Molecular Patterns and Extracellular Vesicles in Secondary Organ Failure Induced by Trauma and Sterile Insults. Front Immunol 9:190
Vera, Nicholas B; Chen, Zhidan; Pannkuk, Evan et al. (2018) Differential mobility spectrometry (DMS) reveals the elevation of urinary acetylcarnitine in non-human primates (NHPs) exposed to radiation. J Mass Spectrom 53:548-559
Lacombe, Jerome; Sima, Chao; Amundson, Sally A et al. (2018) Candidate gene biodosimetry markers of exposure to external ionizing radiation in human blood: A systematic review. PLoS One 13:e0198851
Lee, Younghyun; Pujol Canadell, Monica; Shuryak, Igor et al. (2018) Candidate protein markers for radiation biodosimetry in the hematopoietically humanized mouse model. Sci Rep 8:13557
Rudqvist, Nils; Laiakis, Evagelia C; Ghandhi, Shanaz A et al. (2018) Global Gene Expression Response in Mouse Models of DNA Repair Deficiency after Gamma Irradiation. Radiat Res 189:337-344
Suresh Kumar, M A; Laiakis, Evagelia C; Ghandhi, Shanaz A et al. (2018) Gene Expression in Parp1 Deficient Mice Exposed to a Median Lethal Dose of Gamma Rays. Radiat Res 190:53-62
Zheng, Zhihong; Fan, Shengjun; Zheng, Jing et al. (2018) Inhibition of thioredoxin activates mitophagy and overcomes adaptive bortezomib resistance in multiple myeloma. J Hematol Oncol 11:29
Beach, Tyler A; Groves, Angela M; Johnston, Carl J et al. (2018) Recurrent DNA damage is associated with persistent injury in progressive radiation-induced pulmonary fibrosis. Int J Radiat Biol 94:1104-1115
Ghandhi, Shanaz A; Turner, Helen C; Shuryak, Igor et al. (2018) Whole thorax irradiation of non-human primates induces persistent nuclear damage and gene expression changes in peripheral blood cells. PLoS One 13:e0191402

Showing the most recent 10 out of 185 publications